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Summary
Signaling events mediated by Rho family GTPases orchestrate cytoskeletal dynamics and cell junction formation. The activation of Rho
GTPases is tightly regulated by guanine-nucleotide-exchange factors (GEFs). In this study, we identified a novel Rho-specific GEF
called TEM4 (tumor endothelial marker 4) that associates with multiple members of the cadherin–catenin complex and with several
cytoskeleton-associated proteins. Depending on confluence, TEM4 localized to either actin stress fibers or areas of cell–cell contact. The
junctional localization of TEM4 was independent of actin binding. Depletion of endogenous TEM4 by shRNAs impaired Madin–Darby
canine kidney (MDCK) and human umbilical vein endothelial cell (HUVEC) cell junctions, disrupted MDCK acini formation in 3D
culture and negatively affected endothelial barrier function. Taken together, our findings implicate TEM4 as a novel and crucial
junctional Rho GEF that regulates cell junction integrity and epithelial and endothelial cell function.
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Introduction
The actin cytoskeleton is critical for cell–cell adhesion,
cytokinesis, intracellular trafficking and cell motility (Hall,
1998; Etienne-Manneville and Hall, 2002). Rho GTPases are
molecular binary switches that in their active GTP-loaded state
regulate the assembly, disassembly and contractility of the
cytoskeleton (Narumiya, 1996; Etienne-Manneville and Hall,
2002). In particular, RhoA directs the formation of actin stress
fibers (Ridley and Hall, 1992; Chrzanowska-Wodnicka and
Burridge, 1996); Rac1 promotes the assembly of lamellipodia
and membrane ruffles (Ridley et al., 1992); and Cdc42 regulates
the formation of filopodia (Nobes and Hall, 1995).
A number of recent reports support the hypothesis that the
precise spatiotemporal activation of Rho GTPases by Rho GEFs
(Rossman et al., 2005) is essential for modulating cytoskeletal
events at the cell–cell junctions. For example, p114RhoGEF
regulates apical contractility in epithelial cells by associating
with circumferential myosin IIA (Nakajima and Tanoue, 2011;
Terry et al., 2011). GEF-H1 mediates changes of actin and
microtubule cytoskeleton to modulate cellular activities such as
cytokinesis, cell cycle progression and paracellular permeability
(Ren et al., 1998; Benais-Pont et al., 2003; Aijaz et al., 2005;
Birkenfeld et al., 2007; Chang et al., 2008). Importantly, the
specific activation of RhoA at intercellular junctions is critical for
proper epithelial and endothelial junction formation and integrity
(Terry et al., 2011; Ngok et al., 2012; Ratheesh et al., 2012).
Despite these findings, the current understanding of the Rho-
GEF–Rho signaling axis is limited. Rho GEFs outnumber their
target GTPases by a factor of three. The role of many of these
GEFs in the regulation of cytoskeletal dynamics, as well as their
downstream effects on cell morphology and function are largely
unknown.
To identify new regulators of Rho GTPases at cell junctions,
we expressed a library of mammalian Rho GEFs in MDCK cells
and screened it for junctional localization and for interaction with
junctional proteins. We show that tumor endothelial marker 4
(TEM4; ARHGEF17) associates with the cadherin–catenin
complex and localizes to areas of cell–cell contact in confluent
cells. TEM4 is a Rho-specific GEF that contains an actin-binding
domain (ABD), a Dbl homology (DH) domain and a pleckstrin
homology (PH) domain (Fig. 1A) (Rümenapp et al., 2002; Mitin
et al., 2012). shRNA-mediated knockdown of TEM4 in HUVECs
and MDCK cells resulted in junctional defects and impaired cell
morphology and monolayer function. We propose that TEM4 is a
novel junctional Rho GEF essential for proper intercellular
junction integrity and function in epithelial and endothelial cells.
Results and Discussion
TEM4 localizes to actin stress fibers in sparse cells and
associates with components of the cytoskeleton
Previous work established the presence of an ABD at the N-
terminus of TEM4 (Mitin et al., 2012). In agreement, GFP-tagged
TEM4 colocalized with actin stress fibers when expressed in
subconfluent MDCK cells (Fig. 1B). In contrast, a truncated
variant of TEM4 lacking the entire N-terminal domain including
the ABD, TEM4DN, exhibited cytoplasmic distribution
(Fig. 1B). Using a commercial antibody, we were able to detect
endogenous TEM4 by SDS-PAGE at the predicted 222 kDa
molecular mass (Fig. 1C) both in epithelial (MDCK, Caco-2,



















Actin was shown previously to bind directly to TEM4 (Mitin
et al., 2012). To identify additional TEM4 interacting partners, we
expressed and immunoprecipitated GFP–TEM4 in HeLa cells and
resolved and visualized the samples by SDS-PAGE and silver
staining (Fig. 1D). Protein bands pulled down by GFP–TEM4 but
not GFP (Fig. 1D, white arrows) were excised and subjected to
mass spectrometry analysis (supplementary material Table S1) to
identify potential interacting partners. Our analysis revealed that a-
actinin, actin-related protein 3 (ARP3), gelsolin, flightless 1
homolog, epithelial protein lost in neoplasm (EPLIN), coronin 1C,
filaggrin 2, vimentin and b-tubulin were present in the TEM4
immunoprecipitates in addition to actin (Fig. 1E). A number of
these putative interactions, including interactions with actin, a-
actinin and vimentin (as well as additional interactions with
myosin IIA and IIB) were confirmed by co-immunoprecipitation
experiments (Fig. 1F). As suggested by its inability to bind actin,
TEM4DN did not interact with any of the cytoskeletal proteins
associated with full length TEM4 (Fig. 1D,F).
Fig. 1. TEM4 associates with the cytoskeleton via its N-terminus. (A) Schemes depicting GFP-tagged TEM4 and TEM4DN. ABD, actin-binding domain; DH,
Dbl homology domain; PH, pleckstrin homology domain. (B) Immunofluorescence staining of GFP–TEM4 or GFP–TEM4DN and F-actin in MDCK cells. The
framed region is shown separately to highlight the localization of expressed constructs. Scale bars: 20 mm. (C) Immunoblot analysis of TEM4 and actin in
HUVEC, HeLa, MDCK, Caco-2, Panc1 and UMRC3 cells. (D) Silver staining of proteins co-immunoprecipitated with GFP–TEM4 in HeLa cells. (E) Scheme of
putative TEM4-binding partners. TEM4 interacting partners are grouped as cytoskeleton or junction-associated proteins. (F) Co-immunoprecipitation analysis of
TEM4-interacting partners.


















TEM4 associates with the cadherin–catenin complex and
localizes to areas of cell–cell contact in confluent cells
In addition to cytoskeletal proteins, our proteomics analysis for
TEM4 interacting partners revealed a large number of peptides
related to the cadherin–catenin complex, including a-catenin,
b-catenin, plakoglobin, N-cadherin and desmoplakin
(supplementary material Table S1, Fig. 1E). The putative
interactions with a- and b-catenin were further verified by co-
immunoprecipitation experiments (Fig. 2A,B).
Based on these observations, we postulated that TEM4 is
targeted to areas of cell–cell contact. To test this hypothesis, we
cultured GFP–TEM4 expressing MDCK cells under conditions of
confluence for 5 days to achieve cell polarization with distinct
apical and basolateral regions. GFP–TEM4 localized to cell–cell
contacts, whereas GFP–TEM4DN exhibited cytoplasmic
distribution (Fig. 2C, GFP used as control), indicating that the
N-terminal half of TEM4 is indispensable for junction
localization. In addition, GFP–TEM4 co-localized with cortical
actin and myosin IIB in MDCK cells, proteins associated with
mature adherens junctions (supplementary material Fig. S1A–D).
To assess whether TEM4 is targeted to cell–cell contacts through
its association with actin proteins, we compared the intracellular
localization of GFP–TEM4 with that of two actin-uncoupled
TEM4 mutants – GFP–TEM4 R130D and GFP–TEM4D125–135
(supplementary material Fig. S2) (Mitin et al., 2012). When
expressed in confluent MDCK cells, both TEM4 mutants retained
their junctional localization (Fig. 2D), indicating that the
recruitment of TEM4 to cell–cell contacts is independent of its
Fig. 2. TEM4 localization to areas of
cell–cell contact is independent of actin
association. (A) Co-immunoprecipitation
analysis showing a-catenin and b-catenin
as additional binding partners of GFP–
TEM4. (B) Co-immunoprecipitation
analysis showing endogenous TEM4 in a-
catenin and b-catenin immunoprecipitates
from polarized MDCK cells.
(C) Immunofluorescence staining of GFP,
GFP–TEM4, or GFP–TEM4DN together
with E-cadherin in polarized MDCK cells.
Transfected cells were plated at high
density and cultured for 5 days. The
framed region is shown separately to
highlight the localization of expressed
constructs. Vertical images (z section)
highlight the junctional localization of
GFP–TEM4 (arrowheads) but not GFP or
GPF–TEM4DN. Scale bars: 20 mm.
(D) Immunofluorescence staining of
GFP–TEM4, GFP–TEM4 R130D or
GFP–TEM4 D124–135, and E-cadherin in
polarized MDCK cells. Transfected cells
were seeded at high density and cultured
for 5 days. Note that both actin-uncoupled
TEM4 mutants (R130D and D124-135)
still retain prominent junctional staining.
Scale bars: 20 mm.


















ability to bind actin and likely depends on its association with
components of the cadherin–catenin complex. Combined, the
data suggest that TEM4 is a new member of the cadherin–catenin
complex at mature cell junctions.
Downregulation of TEM4 alters MDCK cell morphology and
acini morphogenesis
To determine the physiological significance of TEM4, we
initially investigated whether downregulation of TEM4 has an
effect on MDCK cell morphology. Depletion of TEM4 by either
of two non-overlapping, canine-specific shRNAs markedly
reduced TEM4 expression (Fig. 3A) and altered the overall
morphology of MDCK cells. Compared to the cuboidal shape
of control cells, silencing TEM4 resulted in an elongated
and spindle-like phenotype (Fig. 3B). Unlike control cells
that polarized properly, TEM4-depleted cells exhibited a
disorganized monolayer morphology (Fig. 3C). Consistent with
this, the localization of cortical actin, afadin, myosin IIA and
myosin IIB to the junctions of TEM-4-depleted cells was
disrupted (supplementary material Fig. S3A), suggesting that
mature cell junctions were compromised. Importantly,
downregulation of TEM4 reduced RhoA activity and myosin
light chain 2 (MLC2) phosphorylation (Fig. 3D), which could
account for the disorganized morphology observed (Fig. 3B,C)
by disrupting apical contractility. Despite the reduced
accumulation of other mature junction components, E-cadherin
and b-catenin were retained at areas of cell–cell contact, which
were more spread and disorganized, consistent with a loss of
apical tension (supplementary material Fig. S3B). Finally, the
observed effects of TEM-4 depletion were not mediated by
altered protein levels of E-cadherin, b-catenin, afadin, myosin
IIA or myosin IIB (supplementary material Fig. S4A).
Fig. 3. TEM4 is important for
epithelial cell junction and proper
acini formation. (A) At 4 days post
infection, MDCK cells expressing the
indicated canine-specific shRNA
were lysed and subjected to
immunoblot analysis for TEM4 and
actin. (B) Immunofluorescence
staining of E-cadherin and b-catenin
in the same set of cells as in A. Cells
were plated at high density and
cultured for 5 days. Scale bars:
20 mm. (C) Vertical images
(z section) of B showing disrupted
monolayer morphology in TEM4-
depleted cells. (D) Immunoblot
analysis of active RhoA and
phosphorylated (pSer19) myosin
light chain 2 (pMLC2) in MDCK
cells expressing the indicated
canine-specific shRNA.
(E) Immunofluorescence staining of
F-actin and nuclei (DAPI) in MDCK
acini expressing the indicated
shRNA. The lines correspond to the
x-z and y-z sections. Scale bars:
20 mm. (F) Quantification of single
versus multi-lumen acini in D,
presented as a percentage of the total
(mean 6 s.e., n53, 50 acini analyzed
per condition per experiment).


















Since cell shape and apical contractility are closely correlated
with the coordination of cell polarity and tissue remodeling
(Mège et al., 2006; Baum and Georgiou, 2011), we hypothesized
that the depletion of TEM4 interferes with the ability of MDCK
cells to form polarized single-lumen acini in 3D cell culture.
Indeed, TEM4 downregulation resulted in a significant increase
in the formation of multi-lumen acini, as assessed by
immunofluorescence staining of F-actin (Fig. 3E,F). Despite a
more diffused and less linear actin organization, the apical
localization of actin was preserved (Fig. 3E), suggesting that
TEM4 depletion does not affect directly epithelial cell
polarization.
Fig. 4. TEM4 plays a role in endothelial monolayer patency and barrier function. (A) At 4 days post infection, HUVECs expressing the indicated human-
specific shRNA were lysed and subjected to immunoblot analysis for TEM4 and actin. (B) Immunoblot analysis of active RhoA and phosphorylated (pSer19)
MLC2 (pMLC2) in HUVECs expressing the indicated human-specific shRNA. (C) Immunofluorescence staining of VE-cadherin and ZO1 in HUVECs expressing
the same set of shRNAs as in A. Scale bars: 20 mm. (D) Immunofluorescence staining of F-actin, afadin, myosin IIA and myosin IIB in HUVECs expressing the
indicated shRNA. Scale bars: 20 mm. (E) Impedance measurement of quiescent HUVEC monolayers. HUVECs expressing the indicated shRNA were plated on
ECIS electrode arrays; impedance at 4000 Hz was recorded every 180 seconds for 48 hours (mean 6 s.e.). Results are representative of three independent
experiments performed in quadruplicate. (F) Representative phase-contrast images of in vitro angiogenesis assays performed using shRNA-expressing HUVECs.
(G) Quantification of the number of tubes in D (mean 6 s.e., n53, four fields per condition analyzed per experiment).


















Depletion of TEM4 leads to defective endothelial cell
junctions and attenuated in vitro angiogenesis
As TEM4 belongs to a family of markers identified in the
vasculature (St Croix et al., 2000), we asked whether it is
important for endothelial junctions and barrier function. Two
non-overlapping human-specific TEM4 shRNAs were used to
downregulate TEM4 expression in HUVECs (Fig. 4A). Similar
to MDCK cells, silencing TEM4 in HUVECs reduced RhoA
activity and MLC2 phosphorylation (Fig. 4B) without altering
the protein levels of junctional and cytoskeletal components
(supplementary material Fig. S4B). Furthermore, TEM4
depletion resulted in disorganized staining of both VE-cadherin
and ZO1 (Fig. 4C), key markers of endothelial junction integrity.
The distribution of afadin, myosin IIA and myosin IIB at areas of
cell–cell contact were disrupted in TEM4-depleted HUVECs
and the circumferential actin belt was absent (Fig. 4D). Next,
we investigated the functional consequence of TEM4
downregulation by measuring the barrier function of confluent,
growth-arrested HUVECs using the Electric Cell-substrate
Impedance System (ECIS). Compared to the trans-endothelial
impedance of control cells, which climbed steadily and plateaued
at around 48 hours, the impedance of TEM4-depleted cells
plateaued at a much earlier time point and the end-point readout
was significantly lower (Fig. 4E). Using a transwell permeability
assay, increased leakage of fluorescence tracer through the
barrier of TEM4-depleted cells was detected (data not shown).
These observations strongly suggest that TEM4 is necessary for
junction maturity and the formation of a patent endothelial
monolayer.
Using an in vitro angiogenesis assay, we then assessed the
endothelial function of control versus TEM4-depleted HUVECs.
TEM4 depletion abrogated the capability of cells to branch out
and form two-dimensional, tube-like structures when plated on
top of matrigel (Fig. 4F,G). The inability of these cells to form a
branched network by making contact with neighboring cells is
consistent with the observed defects in cell adhesion (Fig. 4C,D).
In addition, tube formation of endothelial cells in culture requires
the establishment of polarized, directed cell migration (Egginton
and Gerritsen, 2003), suggesting that TEM4 may play a role in
endothelial cell migration.
Altogether, TEM4 depletion-induced phenomena in
endothelial cells mirror those seen in epithelial cells. Based on
our findings, we propose that TEM4 is a novel junction-
associated Rho GEF that plays a critical role in regulating cell
adhesion, monolayer integrity and barrier function. Previous
studies have indicated that the Rho-specific GEFs p114RhoGEF
and Ect2 (in epithelial cells) (Terry et al., 2011; Ratheesh et al.,
2012), as well as Syx (in endothelial cells) are required for
intercellular junction integrity by locally activating RhoA at the
junctions (Ngok et al., 2012). We postulate that TEM4 also
activates RhoA locally to modulate junction contractility and
stability. The observation that more than one Rho-specific GEFs
are involved in junction function in either MDCK cells or
HUVECs implies non-overlapping functions for these Rho GEFs
and suggests that RhoA activation is required at multiple steps
during junction formation, maturation and maintenance.
Finally, a point mutation in TEM4 that results in a premature
termination codon has been identified in mucosal melanoma
(Bloethner et al., 2008), raising the possibility that mutation of
TEM4 may contribute to tumorigenicity.
Materials and Methods
Cell culture and transfection
HeLa and MDCK cells were cultured in DMEM (Cellgro) containing 10% fetal
bovine serum (Invitrogen) and transfected with TransIT-HeLaMonster (Mirus) or
Lipofectamine 2000 (Invitrogen). HUVECs were cultured in EGM-2 (Lonza).
Acini were grown as reported previously (Wang et al., 1990). Briefly, 46103
MDCK cells were re-suspended in 2% matrigel/media mixture and plated on 100%
matrigel (BD Bioscience) in an 8-well chamber slide. Cells were re-fed with fresh
matrigel/media every 2 days and cultured for 7 days.
DNA constructs, antibodies and reagents
pEGFP-TEM4, pEGFP-TEM4DN, pEGFP-TEM4 R130D and pEGFP-TEM4
D125-135 have been described previously (Mitin et al., 2012). Primary
antibodies used were: rabbit anti-TEM4 (Novus); mouse anti-E-cadherin, anti-
vimentin (BD Bioscience); rabbit anti-MLC2, anti-pSer19 MLC2 (Cell Signaling);
mouse anti-GFP 3E6, anti-p120 (15D2), mouse and rabbit anti-ZO1 (Invitrogen);
rabbit anti-Myosin IIA, anti-Myosin IIB (Covance); mouse anti-RhoA, rabbit anti-
a-actinin (Santa Cruz); rabbit anti-a-catenin, anti-b-catenin, anti-actin, anti-afadin
(Sigma-Aldrich); mouse anti-VE-cadherin (Millipore). Phalloidin (Invitrogen) was
used to stain F-actin. Silver Staining Kit for Mass Spectrometry was purchased
from Pierce.
Immunofluorescence, immunoprecipitation and immunoblotting
Immunofluorescence: cells seeded on cover glass, collagen-coated coverslips, or
matrigel were fixed with methanol or 3% paraformaldehyde as previously reported
(Anastasiadis et al., 2000) and probed with primary antibodies followed by
incubation with Alexa Fluor secondary antibodies (Invitrogen). Images were
acquired with a Zeiss LSM 510 META confocal microscope.
Immunoprecipitation: protein G beads (Invitrogen) were conjugated with anti-
GFP (Invitrogen), a-catenin or b-catenin (Sigma-Aldrich) antibody. Cells were
lysed with TritonX buffer (50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% Triton
X, pH 7.4). Cleared lysates were incubated with prepared beads and washed with
lysis buffer. Bound proteins were eluted by boiling in 26LSB.
Immunoblotting: protein samples were resolved with SDS-PAGE, transferred to
nitrocellulose membrane and probed with primary and peroxidase-conjugated
secondary antibodies (Jackson ImmunoResearch). Bands were detected using ECL
(GE Healthcare).
Rho activity assay
The level of activated RhoA was determined in cells using rhotekin pull-down
assays as previously described (Ngok et al., 2013). Briefly, cells (HUVECs,
MDCK and HeLa) were grown to confluence in 6 cm plates and lysed with Rho
activity lysis buffer (20 mM HEPES, 100 mM NaCl, 10% glycerol, 0.5% NP40,
0.2% deoxycholic acid, 100 mM MgCl2, pH 7.5); cell lysates were collected and
cleared by centrifugation, the supernatants were then incubated with reconstituted
GST-fused rhotekin-RBD protein beads (Cytoskeleton) at 4 C̊ for 45 minutes,
beads were washed three times with the lysis buffer and bound proteins were
eluted by boiling in loading buffer.
shRNA lentivirus production
Lentiviral vectors (pLKO) encoding non-target shRNA along with human specific
shRNAs targeting TEM4 were purchased from Open Biosystems (shRNA2,
NM_014786.2-2407s1c1; shRNA3, NM_014786.2-2902s1c1). Canine-specific
shRNAs were designed using human shRNAs as templates. The specific
sequences were: canine shRNA2, 59-GAGGTTATTCAGAGTATTGTT-39;
canine shRNA5, 59-GTATCTGAATAACCAGGTGTT-39.
Lentivirus was produced as reported previously (Lewis-Tuffin et al., 2010).
Briefly, 293FT cells were transfected with virapower packaging mix (Invitrogen)
and lentiviral vectors using Lipofectamine 2000. MDCK cells and HUVECs
were infected using polybrene (Sigma-Aldrich) and selected for 2 days with
puromycin.
Impedance measurement of endothelial barrier function
ECIS Z (Electric Cell-substrate Impedance System, Applied Biophysics) was used
to measure the trans-endothelial impedance of HUVEC monolayers. 16105
HUVECs were plated on Electrode Arrays (8W10E, Applied Biophysics) and
maintained for 48 hours. Impedance measurement (4000 Hz) was taken every
180 seconds for the duration of the experiment. Each condition was performed in
quadruplicate.
In vitro angiogenesis/tube formation assay
HUVECs were re-suspended in EGM-2 media and seeded at the appropriate
density on an 8-well chamber containing 100% Matrigel (BD Bioscience). Phase-
contrast images were acquired 12 hours post seeding. Tube formation was assessed
by manual counting.
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